Chunk #37 — Summary
Text
Translation of neuropeptide-mediated effects into clinical treatments has typically proven difficult. However, recent data showing that the opioid agonist/partial agonist buprenorphine reduces alcohol intake in msP rats via activation of NOP receptors suggest a possible path toward rapid translation of these preclinical findings into clinical practice.